EULAV Asset Management’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $23.1M | Sell |
|
|||||
|
2020
Q3 | $25.4M | Buy |
|
|||||
|
2020
Q2 | $15.7M | Sell |
|
|||||
|
2020
Q1 | $15.9M | Sell |
|
|||||
|
2019
Q4 | $26.2M | Sell |
|
|||||
|
2019
Q3 | $26.7M | Buy |
|
|||||
|
2019
Q2 | $34.3M | Buy |
|
|||||
|
2019
Q1 | $34.8M | Sell |
|
|||||
|
2018
Q4 | $33.9M | Buy |
|
|||||
|
2018
Q3 | $43.1M | Sell |
|
|||||
|
2018
Q2 | $48M | Buy |
|
|||||
|
2018
Q1 | $41.5M | Sell |
|
|||||
|
2017
Q4 | $48.4M | Buy |
|
|||||
|
2017
Q3 | $54.3M | Hold |
|
|||||
|
2017
Q2 | $47.1M | Buy |
|
|||||
|
2017
Q1 | $28M | Buy |
|
|||||
|
2016
Q4 | $27M | Sell |
|
|||||
|
2016
Q3 | $27.7M | Buy |
|
|||||
|
2016
Q2 | $22.7M | Buy |
|
|||||
|
2016
Q1 | $15.5M | Buy |
|
|||||
|
2015
Q4 | $14.7M | Hold |
|
|||||
|
2015
Q3 | $12M | Sell |
|
|||||
|
2015
Q2 | $15M | Hold |
|
|||||
|
2015
Q1 | $14.4M | Hold |
|
|||||
|
2014
Q4 | $15.4M | Hold |
|
|||||
|
2014
Q3 | $13.8M | Sell |
|
|||||
|
2014
Q2 | $14.8M | Hold |
|
|||||
|
2014
Q1 | $14.4M | Sell |
|
|||||
|
2013
Q4 | $13.4M | Hold |
|
|||||
|
2013
Q3 | $11.7M | Sell |
|
|||||
|
2013
Q2 | $11.5M | Buy |
|